---
title: "MRNA FUND  II LP — Ownership Dossier"
canonical: https://whiteintel.dev/entity/d4e85058-e742-5111-815c-166d80ab4211
json: https://whiteintel.dev/api/public/dossier/d4e85058-e742-5111-815c-166d80ab4211
identifier: sec:0001161302
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# MRNA FUND  II LP

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001161302`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/d4e85058-e742-5111-815c-166d80ab4211  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/d4e85058-e742-5111-815c-166d80ab4211  

## Ownership & control

### Holdings / subsidiaries

- **LYNX THERAPEUTICS INC** (other) — https://whiteintel.dev/entity/4b5de74c-0aea-50a9-9c40-34d0f5d89677
- **TRUBION PHARMACEUTICALS, INC** (tenpercentowner) — https://whiteintel.dev/entity/4ff3540a-9f80-569c-beed-b98c83602a21
- **CYBERKINETICS NEUROTECHNOLOGY SYSTEMS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/593c3ad5-a407-5f8d-86e9-ae6dd5ba1aa6

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **MRNA FUND  II LP**. Human view: https://whiteintel.dev/entity/d4e85058-e742-5111-815c-166d80ab4211 · Structured JSON: https://whiteintel.dev/api/public/dossier/d4e85058-e742-5111-815c-166d80ab4211._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._